I-Paxlovid Boceprevir Intermediate CAS 565456-77-1 Assay ≥99.0%
I-Commercial Supply PF-07321332 I-Paxlovid Izixhumanisi Ezihlobene Nekhwalithi Ephezulu
I-L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
I-Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
I-Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Igama Lekhemikhali | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Omqondofana | I-Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Inombolo ye-CAS | 565456-77-1 |
Inombolo yeCAT | I-RF-PI318 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C9H15NO2.ClH |
Isisindo samangqamuzana | 205.683 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe Kuya Kumhlophe |
Ukuhlonza A | I-IR: Ifana Nereferensi Into |
Ukuhlonza B | Isikhathi Sokugcina: Sifana Nereferensi Into |
I-Enantiomer | ≤0.15% |
Ukungcola Okuhlobene (nge-HPLC) | |
Ukungcola Okungaziwa | ≤0.20% |
Ukungcola Okuphelele | ≤1.0% |
Amanzi | ≤0.50% |
Izinsalela ekushiseni | ≤0.10% |
Izinsimbi Ezisindayo | ≤20ppm |
Isivivinyo | ≥99.0% |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | Okumaphakathi kwe-PF-07321332 Paxlovid (CAS 2628280-40-8) kanye ne-Boceprevir (CAS 394730-60-0) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) iphuma ku-azabicyclohexane esetshenziswa ekulungiseleleni i-hepatitis C. virus (HCV) NS3 serine protease inhibitor.Kuphakathi kwe-PF-07321332 Paxlovid (CAS 2628280-40-8) kanye ne-Boceprevir (CAS 394730-60-0).I-PF-07321332 iyi-inhibitor enamandla futhi esebenza ngomlomo i-SARS-CoV 3C-like protease (3CLPRO) .I-PF-07321332 iqondise kugciwane le-SARS-CoV-2 futhi ingasetshenziselwa ukucwaninga kabusha kwe-COVID-19.I-Boceprevir (INN, igama lokuhweba i-Victrelis) iyi-protease inhibitor esetshenziswa njengokwelapha i-hepatitis C genotype 1. Ibophezela kusayithi elisebenzayo le-HCV nonstructural 3 NS3 (HCV).Yayithuthukiswa yi-Schering-Plough, kodwa manje ithuthukiswa yi-Merck kusukela i-Schering yatholwa ngo-2009. Yagunyazwa yi-FDA ngoMeyi 13, 2011.